ICRA upgrades ratings assigned to Hikal’s bank facilities

14 Nov 2016 Evaluate

Credit Rating agency, ICRA has upgraded rating assigned to Hikal’s long-term rating to ‘BBB+’ from ‘BBB’ with stable outlook. The credit rating agency has also reaffirmed rating assigned to company’s short term rating of A2.

Hikal is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries. It collaborates with innovator companies and offer solutions in Contract Research, Custom Synthesis and Custom Manufacturing. Its people have extensive expertise in multi-disciplinary project management.


Hikal Share Price

227.30 -0.35 (-0.15%)
31-Dec-2025 11:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.85
Dr. Reddys Lab 1266.25
Cipla 1498.35
Zydus Lifesciences 911.50
Lupin 2096.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×